bioMérieux submits enhanced BIOFIRE® BCID2 Panel for FDA clearance
bioMérieux, a world leader in the field of in vitro diagnostics, announces that BioFire Diagnostics, its molecular biology affiliate, has submitted to the Food and Drug Administration for 510(k) clearance of the BIOFIRE® Blood Culture Identification 2 (BCID2) Panel. The BIOFIRE® BCID2 Panel includes several additional pathogens, an expanded list of antimicrobial resistance genes, and many revised targets compared to the existing BIOFIRE® BCID Panel.d about 9,800.
World Antibiotic Awareness Week, 18-24 November, 2019
The 2019 edition of World Antibiotic Awareness Week (WAAW) will take place from November 18th – 24th. This annual campaign, organized by the World Health Organization (WHO), aims to increase awareness of drug-resistant infections and to encourage best practices among the general public, health workers and policy makers to avoid the further emergence and spread of antibiotic resistance.
Webinar (hosted by CIDRAP): Value of Diagnostics to Enhance Antimicrobial Stewardship
CIDRAP-ASP WEBINAR NOW AVAILABLE ON-LINE
- Legal Notice
- Copyright 2022 bioMérieux SA